Technical Analysis for MRUS - Merus N.V.

Grade Last Price % Change Price Change
grade D 13.26 -2.14% -0.29
MRUS closed down 2.14 percent on Wednesday, January 16, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRUS trend table...

Date Alert Name Type % Chg
Jan 16 50 DMA Resistance Bearish 0.00%
Jan 16 MACD Bearish Signal Line Cross Bearish 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Down 3 Days in a Row Weakness 0.00%
Jan 15 Fell Below 20 DMA Bearish -2.14%
Jan 15 Fell Below 50 DMA Bearish -2.14%
Jan 15 Wide Bands Range Expansion -2.14%
Jan 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -9.55%
Jan 14 NR7 Range Contraction -9.55%
Jan 14 Wide Bands Range Expansion -9.55%

Older signals for MRUS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Merus B.V., a clinical-stage immuno-oncology company, engages in developing bispecific antibody therapeutics. Its lead bispecific antibody candidate is MCLA-128, which is in Phase I/II clinical trials in Europe for the treatment of various solid tumors, including breast, colorectal, and ovarian cancers. The company also develops MCLA-117, a bispecific antibody candidate that is expected to commence a Phase I/II clinical trial for the treatment of patients with acute myeloid leukemia, as well as for the treatment of myelodysplastic syndrome in pre-clinical studies. Its pre-clinical bispecific antibody candidates include MCLA-134, MCLA-114, and MCLA-145, as well as other early research projects. The company has a strategic collaboration with Gustave Roussy to develop innovative bispecific antibodies for therapeutic immuno-oncology applications. Merus B.V. was founded in 2003 and is headquartered in Utrecht, the Netherlands.
Is MRUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.74
52 Week Low 11.0
Average Volume 47,862
200-Day Moving Average 17.9358
50-Day Moving Average 13.5919
20-Day Moving Average 13.9053
10-Day Moving Average 14.637
Average True Range 1.5044
ADX 18.89
+DI 20.0196
-DI 18.9735
Chandelier Exit (Long, 3 ATRs ) 13.2368
Chandelier Exit (Short, 3 ATRs ) 15.7932
Upper Bollinger Band 16.2341
Lower Bollinger Band 11.5765
Percent B (%b) 0.36
BandWidth 33.495142
MACD Line 0.2953
MACD Signal Line 0.3423
MACD Histogram -0.047
Fundamentals Value
Market Cap 257.19 Million
Num Shares 19.4 Million
EPS -5.48
Price-to-Earnings (P/E) Ratio -2.42
Price-to-Sales 36.17
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.84
Resistance 3 (R3) 14.86 14.35 14.57
Resistance 2 (R2) 14.35 13.95 14.34 14.48
Resistance 1 (R1) 13.81 13.70 13.56 13.79 14.40
Pivot Point 13.30 13.30 13.18 13.29 13.30
Support 1 (S1) 12.76 12.90 12.51 12.74 12.12
Support 2 (S2) 12.25 12.65 12.24 12.04
Support 3 (S3) 11.71 12.25 11.95
Support 4 (S4) 11.69